MetLife Investment Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

MetLife Investment Management’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-12,376	Closed	-$418K	–	2603
2021 Q2	$418K	Hold	12,376	–	–	﹤0.01%	1676
2021 Q1	$289K	Hold	12,376	–	–	﹤0.01%	1831
2020 Q4	$356K	Hold	12,376	–	–	﹤0.01%	1659
2020 Q3	$251K	Hold	12,376	–	–	﹤0.01%	1723
2020 Q2	$372K	Buy	12,376 +3,776	+44%	+$136K	﹤0.01%	1537
2020 Q1	$270K	Buy	8,600 +1,464	+21%	+$50.9K	﹤0.01%	1532
2019 Q4	$336K	Buy	+7,136	New	+$206K	﹤0.01%	1671

MetLife Investment Management's CNST Position: Q3 2021 in Review

MetLife Investment Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 12,376 shares — an estimated $418K sold.

MetLife Investment Management first reported a position in CNST in Q4 2019 and held it in 7 quarters. The position peaked at $418K in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

MetLife Investment Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
MetLife Investment Management sold 12,376 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $418K.
MetLife Investment Management first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2019 and held it in 7 quarters.
MetLife Investment Management's Constellation Pharmaceuticals, Inc. position peaked at $418K in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on MetLife Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.